Clinical Trials Logo

Clinical Trial Summary

Investigation of the efficacy of Acceptance and Commitment Therapy (ACT) for the psychological treatment of hypersexuality.


Clinical Trial Description

After being informed about the study, all patients giving written informed consent will be assessed to determine eligibility for study entry. Patients who meet eligibility requirements will receive psychological intervention consisting in an 8-session individual on line-delivered ACT-based treatment. The participants will be assessed through self-report instruments before and after treatment and at 3 months follow-up. The clinical trial will not include a control group. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05572372
Study type Interventional
Source Universidad Europea de Madrid
Contact
Status Completed
Phase N/A
Start date January 8, 2022
Completion date December 31, 2022

See also
  Status Clinical Trial Phase
Completed NCT00467558 - Double-Blind Naltrexone in Compulsive Sexual Behavior Phase 2
Recruiting NCT06408545 - Acceptance and Commitment Therapy for Problematic Chemsex N/A
Not yet recruiting NCT06406296 - Effectiveness of ACT for Problematic Chemsex N/A
Enrolling by invitation NCT04634175 - Mind-body Intervention for Compulsive Sexual Behavior Disorder N/A
Completed NCT02300051 - Intervention Study for Individuals With Compulsive Sexual Behavior N/A
Completed NCT03495414 - Neurobiological Underpinnings to Hypersexual Disorder